Acadia Healthcare (NASDAQ:ACHC) Rating Lowered to Sell at StockNews.com

Acadia Healthcare (NASDAQ:ACHC) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday.

ACHC has been the subject of several other reports. Cantor Fitzgerald reissued a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, March 5th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a research report on Thursday, April 25th. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Finally, Barclays reduced their price objective on Acadia Healthcare from $100.00 to $91.00 and set an “overweight” rating for the company in a report on Thursday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $88.89.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $66.12 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 0.67. The business has a 50 day simple moving average of $76.77 and a 200-day simple moving average of $77.52. Acadia Healthcare has a 12 month low of $64.74 and a 12 month high of $87.77. The stock has a market capitalization of $6.11 billion, a PE ratio of -472.25, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, May 1st. The company reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The company had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. During the same quarter last year, the business earned $0.75 EPS. The business’s revenue was up 9.1% on a year-over-year basis. Equities analysts predict that Acadia Healthcare will post 3.56 earnings per share for the current year.

Insider Buying and Selling

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds have recently made changes to their positions in the business. Headlands Technologies LLC acquired a new stake in Acadia Healthcare in the 3rd quarter worth about $25,000. GAMMA Investing LLC purchased a new position in shares of Acadia Healthcare during the 4th quarter worth about $26,000. Mather Group LLC. purchased a new stake in Acadia Healthcare in the first quarter valued at approximately $48,000. Fifth Third Bancorp increased its position in Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at $96,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.